BioCentury
ARTICLE | Clinical News

OMS ElectroImmunotherapy: Phase II started

August 24, 2015 7:00 AM UTC

OncoSec said the University of California San Francisco began an open-label, U.S. Phase II trial to evaluate intratumoral ImmunoPulse IL-12 given on days 1, 5 and 8 of every other 3-week cycle plus I...